Central Nervous System (CNS) Biomarkers Market Size, Share and Growth Outlook, 2026: Analysis By Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers, Predictive Biomarkers), By Application (Clinical Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment), By Disease Indication (Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis , Traumatic Brain Injury , Amyotrophic Lateral Sclerosis ), By End User (Hospitals and Clinics, Diagnostic Laboratories, Biopharmaceutical Companies, Academic and Research Centers) Companies, and Country Forecast, 2021 to 2034
Global Central Nervous System (CNS) Biomarkers Market size is forecast to increase from $7.88 Billion in 2026 to $19.93 Billion in 2034 at a CAGR of 12.3% between 2026 and 2034.